203 related articles for article (PubMed ID: 25832867)
1. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.
Zhang Z; Liu P; Wang J; Gong T; Zhang F; Ma J; Han N
Med Oncol; 2015 May; 32(5):149. PubMed ID: 25832867
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
[TBL] [Abstract][Full Text] [Related]
3. Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression.
Ieta K; Ojima E; Tanaka F; Nakamura Y; Haraguchi N; Mimori K; Inoue H; Kuwano H; Mori M
Int J Cancer; 2007 Jul; 121(1):33-8. PubMed ID: 17354233
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
Xie C; Powell C; Yao M; Wu J; Dong Q
Int J Biochem Cell Biol; 2014 Feb; 47():113-7. PubMed ID: 24361302
[TBL] [Abstract][Full Text] [Related]
5. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.
Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y
Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161
[TBL] [Abstract][Full Text] [Related]
6. The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.
Zhang S; You X; Zheng Y; Shen Y; Xiong X; Sun Y
J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36548081
[TBL] [Abstract][Full Text] [Related]
7. UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation.
Wang L; Zhao S; Wang Y; Liu J; Wang X
BMC Cancer; 2024 Apr; 24(1):497. PubMed ID: 38637730
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide suppresses non-small cell lung cancer GLC-82 cells growth via B-Raf/MAPK/Erk pathway.
Lin M; Bi H; Yan Y; Huang W; Zhang G; Zhang G; Tang S; Liu Y; Zhang L; Ma J; Zhang J
Oncotarget; 2017 Apr; 8(14):23436-23447. PubMed ID: 28423582
[TBL] [Abstract][Full Text] [Related]
9. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
[TBL] [Abstract][Full Text] [Related]
10. Effects of ubiquitin-conjugating enzyme 2C on invasion, proliferation and cell cycling of lung cancer cells.
Tang XK; Wang KJ; Tang YK; Chen L
Asian Pac J Cancer Prev; 2014; 15(7):3005-9. PubMed ID: 24815438
[TBL] [Abstract][Full Text] [Related]
11. CD59 is overexpressed in human lung cancer and regulates apoptosis of human lung cancer cells.
Li B; Lin H; Fan J; Lan J; Zhong Y; Yang Y; Li H; Wang Z
Int J Oncol; 2013 Sep; 43(3):850-8. PubMed ID: 23835643
[TBL] [Abstract][Full Text] [Related]
12. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
[TBL] [Abstract][Full Text] [Related]
13. Involvement of ubiquitin-conjugating enzyme E2C in proliferation and invasion of prostate carcinoma cells.
Shuliang S; Lei C; Guangwu J; Changjie L
Oncol Res; 2013; 21(3):121-7. PubMed ID: 24512726
[TBL] [Abstract][Full Text] [Related]
14. SIRT3 is correlated with the malignancy of non-small cell lung cancer.
Xiong Y; Wang M; Zhao J; Wang L; Li X; Zhang Z; Jia L; Han Y
Int J Oncol; 2017 Mar; 50(3):903-910. PubMed ID: 28197634
[TBL] [Abstract][Full Text] [Related]
15. Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
Liu Y; Huang F; Chen H; Peng Q; Zhao C; Miao L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1044-1052. PubMed ID: 33051417
[TBL] [Abstract][Full Text] [Related]
16.
Liu Y; Zhao R; Chi S; Zhang W; Xiao C; Zhou X; Zhao Y; Wang H
Mol Cancer Res; 2020 Feb; 18(2):204-215. PubMed ID: 31662448
[TBL] [Abstract][Full Text] [Related]
17. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
18. Differential expression and activation of epidermal growth factor receptor 1 (EGFR1), ERK, AKT, STAT3, and TWIST1 in nonsmall cell lung cancer (NSCLC).
Gorgisen G; Ozes D; Pehlivanoglu S; Erdogan A; Dertsiz L; Ozbilim G; Ozbudak IH; Savas B; Ozes ON
Exp Lung Res; 2013 Nov; 39(9):387-98. PubMed ID: 24117170
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
20. UBE2C induces EMT through Wnt/β‑catenin and PI3K/Akt signaling pathways by regulating phosphorylation levels of Aurora-A.
Wang R; Song Y; Liu X; Wang Q; Wang Y; Li L; Kang C; Zhang Q
Int J Oncol; 2017 Apr; 50(4):1116-1126. PubMed ID: 28260026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
